13D/13G Filings - Anebulo Pharmaceuticals Inc. (ANEB)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-03-17
4:51 pm
Purchase
2024-12-3113GAnebulo Pharmaceuticals, Inc.
ANEB
Mangrove Partners IM, LLC2,525,252
6.150%
2,525,252increase
(New Position)
Filing
History
2025-02-27
07:41 am
Unchanged
2025-02-2413DAnebulo Pharmaceuticals, Inc.
ANEB
English Aron R.21,929,880
51.100%
0
(Unchanged)
Filing
History
2025-02-14
4:32 pm
Purchase
2024-12-3113GAnebulo Pharmaceuticals, Inc.
ANEB
Nantahala Capital Management, LLC3,547,398
8.630%
3,547,398increase
(New Position)
Filing
History
2024-12-26
9:42 pm
Purchase
2024-12-2313DAnebulo Pharmaceuticals, Inc.
ANEB
English Aron R.21,929,880
51.100%
13,931,787increase
(+174.19%)
Filing
History
2021-05-17
5:17 pm
Purchase
2021-05-0613DAnebulo Pharmaceuticals, Inc.
ANEB
English Aron R.7,998,093
34.400%
7,998,093increase
(New Position)
Filing
History